Browse by author
Lookup NU author(s): Professor John IsaacsORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2020 Future Medicine Ltd.. All rights reserved.Aim: TNF inhibitor drugs are a treatment option for rheumatoid arthritis, but response is not universal. Response is typically measured using the composite 4-component (4C) disease activity score 28 (DAS28) which contains more subjective measures. This study used a validated 2-component (2C) DAS28 score to determine whether SNPs associated with response were replicated in the UK population. Materials and methods: A literature review identified TNF inhibitor response SNPs. Linear regression was conducted to replicate associations with 4C or 2C-DAS28 response. Results: Eighteen independent SNPs were analyzed in 1828 patients. One and four associations with 4C and 2C-DAS28 response respectively were identified (p ≤ 0.05). Conclusion: Further genetic associations were replicated using the 2C-DAS28 which may reflect the objective nature of 2C-AS28.
Author(s): Gilani SSA, Nair N, Plant D, Hyrich K, Morgan AW, Morris AP, Wilson AG, Isaacs JD, Barton A, Bluett J
Publication type: Article
Publication status: Published
Journal: Pharmacogenomics
Year: 2020
Volume: 21
Issue: 16
Pages: 1151-1156
Online publication date: 30/10/2020
Acceptance date: 27/03/2020
ISSN (print): 1462-2416
ISSN (electronic): 1744-8042
Publisher: Future Medicine Ltd.
URL: https://doi.org/10.2217/pgs-2020-0043
DOI: 10.2217/pgs-2020-0043
PubMed id: 33124499
Altmetrics provided by Altmetric